tirzepatide 7.5 mg/0.5 ml Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound (Tirzepatide) 7.5mg/0.5mL Pre-Filled Pens

Patients with diabetes and pre-existing diabetic retinopathy should be monitored for worsening of this condition

Which Weight Loss Medication Should You Take

p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis

Metformin may still be preferred when the main concern is cost, long-term familiarity, or avoiding injectable therapy

Product Specifications Physical FormLyophilized powder AppearanceWhite to off-white powder PurityHPLC-verified (see COA) Molecular FormulaC187H291N45O59 Molecular Weight4113.58 g/mol CAS Number910463-68-2 Amino Acid SequenceHis-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(Glu-2xOEG-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH Research Applications Investigated in preclinical models for GLP-1 receptor signaling and downstream cAMP pathways